VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
VRDN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
VRDNViridian Therapeutics, Inc.
$19.40$1.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksVRDNQuarterly Balance Sheet

Viridian Therapeutics, Inc. (VRDN) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Viridian Therapeutics, Inc. (VRDN) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

VRDN Balance Sheet

Quarterly statement

VRDN Balance Sheet

Viridian Therapeutics, Inc. (VRDN) balance sheet — 14-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets1.08B784.74M894.23M571.91M578.75M657.24M738.46M767.36M581.66M626.82M486.48M323.84M346.33M373.86M424.55M437.36M166.15M179.39M200.16M217.94M
Cash & Short-Term Investments981.53M762.18M874.65M490.9M563.36M636.63M717.58M753.24M571.37M613.19M477.37M313.01M334.29M373.86M424.55M431.32M161.21M175.43M196.97M213.81M
Cash Only164.99M176.35M212.38M169.65M117.32M116.22M99.59M200.32M107.67M91.64M102.83M111.6M87.08M88.52M155.58M344.21M31.29M30.86M42.3M138.88M
Short-Term Investments816.54M585.84M662.27M321.25M446.03M520.42M617.99M552.92M463.7M521.55M374.54M201.41M247.21M285.34M268.97M87.11M129.91M144.57M154.67M74.94M
Accounts Receivable00070M00014K0102K102K102K102K128K102K398K693K522K451K479K
Days Sales Outstanding---91.26---14.98-128.92130.33130.33145.35105.61219.0542215.95202.71199.91559.52
Inventory0000000000000-8.74M-6.62M00000
Days Inventory Outstanding--------------------
Other Current Assets99.74M22.56M19.58M11.01M15.39M20.61M20.88M14.1M10.3M13.53M9.01M10.73M11.94M8.62M6.52M00000
Total Non-Current Assets15.96M4.27M5.18M5.22M3.57M3.74M3.94M4.54M4M3.56M3.95M4.92M5.14M12.78M10.54M3.23M3.66M3.78M3.55M3.27M
Property, Plant & Equipment03.38M3.65M3.71M3.07M3.25M3.44M3.69M3.34M3.01M3.34M3.65M3.95M3.06M2.94M2.07M2.15M2.23M2.06M1.81M
Fixed Asset Turnover-0.04x0.04x20.83x0.02x0.02x0.02x0.02x0.02x0.02x0.02x0.02x0.02x0.03x0.04x0.57x0.12x0.10x0.11x0.11x
Goodwill00000000000000000000
Intangible Assets10M0000000000000000000
Long-Term Investments00000000000000000000
Other Non-Current Assets5.96M888K1.54M1.52M506K489K501K853K659K555K604K1.26M1.18M9.73M7.61M1.15M1.51M1.54M1.49M1.46M
Total Assets1.1B789.02M899.42M577.14M582.32M660.98M742.4M771.9M585.66M630.38M490.42M328.76M351.47M386.64M435.09M440.58M169.81M183.16M203.71M221.21M
Asset Turnover0.00x0.00x0.00x0.12x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x
Asset Growth %88.42%19.37%21.15%-25.23%-0.57%4.85%51.38%134.79%66.63%63.04%12.72%-25.38%106.97%111.09%113.58%99.17%43.66%49.12%55.2%573.73%
Total Current Liabilities63.79M51.8M70.7M50.7M52.59M33.73M47.87M41.36M36.76M26.13M26.64M23.25M28.66M29.59M33.35M25.21M21.39M14.39M13.64M14.34M
Accounts Payable013.31M8.68M10.06M8.52M3.89M2.14M6.34M3.14M2.68M2.24M3.73M4.13M7.87M14.23M12.15M4.06M2.54M2.33M3.73M
Days Payables Outstanding-8.18K2.69K-----------30.8733.7213.8312.3412.4534.68
Short-Term Debt0738K0730K8.44M0002.96M00000000000
Deferred Revenue (Current)0274K367K372K288K288K288K288K288K288K288K288K288K288K288K288K288K288K289K288K
Other Current Liabilities63.79M29.12M19.66M28.82M8.19M5.2M10.74M10.11M20.83M7.16M12.75M10.76M17.76M17.23M4.87M3.68M13.88M1.65M3.75M7.54M
Current Ratio16.95x15.15x12.65x11.28x11.01x19.49x15.43x18.55x15.82x23.99x18.26x13.93x12.09x12.64x12.73x17.35x7.77x12.47x14.68x15.20x
Quick Ratio16.95x15.15x12.65x11.28x11.01x19.49x15.43x18.55x15.82x23.99x18.26x13.93x12.09x12.93x12.93x17.35x7.77x12.47x14.68x15.20x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities371.34M101.2M106.56M23.47M14.57M22.78M22.89M23.04M19.56M21.72M21.77M21.93M6.95M6.5M6.68M6.36M6.53M2.14M2.36M2.27M
Long-Term Debt242.16M50.44M49.94M20.89M12.35M20.68M20.58M20.52M17.49M20.33M20.2M20M4.71M4.68M4.64M4.61M4.58M000
Capital Lease Obligations0002.2M0000000000000000
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities129.18M14.68M22.37M382K2.08M1.88M2.02M2.16M1.65M896K989K1.29M1.53M1.04M1.17M813K938K1.06M1.21M2.27M
Total Liabilities435.14M153.01M177.25M74.17M67.16M56.51M70.76M64.4M56.33M47.85M48.4M45.18M35.61M36.09M40.03M31.57M27.92M16.52M15.99M16.61M
Total Debt242.16M51.17M50.69M23.82M21.34M21.22M21.09M21.11M20.96M21.06M21.05M20.82M5.51M5.31M5.26M5.18M5.17M579K520K430K
Net Debt77.17M-125.17M-161.69M-145.83M-95.98M-94.99M-78.5M-179.21M-86.71M-70.58M-81.78M-90.78M-81.57M-83.2M-150.32M-339.03M-26.13M-30.28M-41.78M-138.44M
Debt / Equity0.37x0.08x0.07x0.05x0.04x0.04x0.03x0.03x0.04x0.04x0.05x0.07x0.02x0.02x0.01x0.01x0.04x0.00x0.00x0.00x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage-14.30x-29.30x-17.21x-60.78x-194.98x-147.31x-91.92x-75.38x-107.87x-81.70x-71.99x-85.37x-330.70x-412.04x-292.06x-181.62x-191.97x--9693.67x-
Total Equity662.1M636.01M722.17M502.97M515.17M604.47M671.64M707.5M529.34M582.53M442.02M283.58M315.86M350.55M395.06M409.01M141.9M166.64M187.72M204.59M
Equity Growth %28.52%5.22%7.52%-28.91%-2.68%3.77%51.95%149.49%67.59%66.18%11.89%-30.67%122.59%110.36%110.46%99.91%43.46%57.21%56.38%872.3%
Book Value per Share6.146.228.526.156.317.438.3910.658.299.538.906.507.308.309.7412.125.116.3816.7818.29
Total Shareholders' Equity662.1M636.01M722.17M502.97M515.17M604.47M671.64M707.5M529.34M582.53M442.02M283.58M315.86M350.55M395.06M409.01M141.9M166.64M187.72M204.59M
Common Stock1.13M1.02M1.02M822K817K816K810K792K639K638K540K437K436K431K414K402K285K272K239K194K
Retained Earnings-1.57B-1.44B-1.34B-1.22B-1.18B-1.08B-995.86M-916.13M-839.44M-774.45M-725.91M-659.05M-611.39M-556.33M-488.17M-442.39M-413.48M-383.99M-358.3M-329.35M
Treasury Stock00000000000000000000
Accumulated OCI-1.15M-558K447K363K69K245K-10K932K-543K-367K338K-64K-173K-174K-390K-940K-1.08M-935K-157K-3K
Minority Interest00000000000000000000